BRIEF published on 04/15/2025 at 12:13, 7 months 19 days ago Moody's Affirms 'Baa1' Rating for Amprion, Outlook Now Negative Investment Moody's Rating Amprion Transmission Grid Debt Investors
PRESS RELEASE published on 04/15/2025 at 12:08, 7 months 19 days ago Moody’s affirms 'Baa1' rating of Amprion and changes outlook to negative Moody's affirms 'Baa1' rating of Amprion with negative outlook, citing increased investment volume. Amprion plans €36.4 billion for grid expansion 2025-2029 to support Germany's energy transition Moody's Amprion Baa1 Rating Investment Volume Germany Energy Transition
BRIEF published on 04/14/2025 at 18:01, 7 months 20 days ago Fitch Ratings Reaffirms Amprion's 'BBB+' Rating with Stable Outlook Investment Energy Transition Fitch Ratings Amprion GmbH BBB+
PRESS RELEASE published on 04/14/2025 at 17:56, 7 months 20 days ago Fitch Ratings again affirms 'BBB+' rating with stable outlook for Amprion Fitch Ratings affirms 'BBB+' rating with stable outlook for Amprion transmission system operator. Amprion plans €36.4 billion investment in grid expansion and upgrade 2025-2029 Investment Fitch Ratings Transmission System Operator Amprion BBB+
BRIEF published on 04/10/2025 at 10:06, 7 months 24 days ago Amprion Sees Record Growth in 2024 and Plans Major Grid Expansion Renewable Energy Financial Performance Grid Expansion Amprion 2024 Results
PRESS RELEASE published on 04/10/2025 at 10:01, 7 months 24 days ago Amprion looks back on a successful 2024 and steps up grid expansion Amprion reports successful 2024 performance with €4 billion investments, aims €36.4 billion investment by 2029. Emphasizes affordable energy transition, grid expansion pace, and financial growth Investment Energy Transition Grid Expansion Amprion 2024 Performance
BRIEF published on 03/24/2025 at 13:44, 8 months 11 days ago Amprion GmbH Announces 2024 Annual Results Conference Call Conference Call Investor Relations Energy Sector Amprion GmbH Annual Report 2024
PRESS RELEASE published on 03/24/2025 at 13:39, 8 months 11 days ago Invitation to the 2024 annual results conference call for investors and analysts Amprion GmbH invites investors and analysts to the 2024 annual results conference call on April 10, 2025. Chief Financial Officer to present insights in English Investors Analysts 2024 Financial Year Amprion GmbH Annual Results Conference Call
BRIEF published on 12/18/2024 at 14:26, 11 months 17 days ago Amprion Completes €850 Million Capital Increase Capital Increase Energy Transition Amprion GmbH Shareholder Equity Electricity Grid Investment
PRESS RELEASE published on 12/18/2024 at 14:21, 11 months 17 days ago Amprion GmbH successfully completes €850 million capital increase Amprion GmbH successfully completes €850 million capital increase, strengthening financing for grid expansion in Germany Financing Investment Capital Increase Amprion GmbH Electricity Grid
Published on 12/05/2025 at 02:35, 3 hours 32 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 7 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 2 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 7 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 37 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 16 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 42 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 52 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 56 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 7 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 22 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 23 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 6 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
